References 1. Aggarwal B, Kumar A, Bharti A (2003) Anticancer potential of curcumin: preclinical and clinical studies. Anticancer Res 23(1A): 363–398. 2. Singh S (2007) From exotic spice to modern drug? Cell 130: 765–768. 3. Kuttan R, Bhanumathy P, Nirmala K, George M (1985) Potential anticancer activity of turmeric (Curcuma longa). Cancer Lett 29(2): 197–202. 4. Walters DK, Muff R, Langsam B, Born W, Fuchs B (2008) Cytotoxic effects of curcumin on osteosarcoma cell lines. Invest New Drugs 26(4): 289–97. Epub 2007 Dec 11. 5. Arndt CA, Crist WM (1999) Common musculoskeletal tumors of childhood and adolescence. N Engl J Med 341: 342–352. 6. Marina N, Gebhardt M, Teot L, Gorlick R (2004) Biology and therapeutic advances for pediatric osteosarcoma. Oncologist 9: 422–441. 7. Bielack SS, Kempf-Bielack B, Delling G, Exner GU, Flege S, et al. (2002) Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols. J Clin Oncol 20(3): 776–90. 8. Baum ES, Gaynon P, Greenberg L, Krivit W, Hammond D (1981) Phase II trail cisplatin in refractory childhood cancer: children’s cancer study group report. Cancer Treat Rep 65: 815–822. 9. Smith MA, Ungerleider RS, Horowitz ME, Simon R (1991) Influence of doxorubicin dose intensity on response and outcome for patients with osteogenic sarcoma and Ewing’s sarcoma. J Natl Cancer Inst 83: 1460–1470. 10. Meistrich ML, Chawla SP, da Cunha MF, Johnson SL, Plager C, et al. (1989) Recovery of sperm production after chemotherapy for osteosarcoma. Cancer 63: 2115–2123. 11. Goorin AM, Shuster JJ, Baker A, Horowitz ME, Meyer WH, et al. (1991) Changing pattern of pulmonary metastases with adjuvant chemotherapy in patients with osteosarcoma: results from the multiinstitutional osteosarcoma study. J Clin Oncol 9: 600–5. 12. Kekre N, Griffin C, McNulty J, Pandey S (2005) Pancratistatin causes early activation of caspase-3 and the flipping of phosphatidyl serine followed by rapid apoptosis specifically in human lymphoma cells. Cancer Chemother Pharmacol 56(1): 29–38. 13. McLachlan A, Kekre N, McNulty J, Pandey S (2005) Pancratistatin: a natural anti-cancer compound that targets mitochondria specifically in cancer cells to induce apoptosis. Apoptosis 10(3): 619–630. 14. Siedlakowski P, McLachlan-Burgess A, Griffin C, Tirumalai SS, McNulty J, et al. (2007) Synergy of Pancratistatin and Tamoxifen on breast cancer cells in inducing apoptosis by targeting mitochondria. Cancer Biol Ther 7(3): 376–384. 15. Chatterjee SJ, McNulty J, Pandey S (2010) Sensitization of human melanoma cells by tamoxifen to apoptosis induction by pancratistatin, a nongenotoxic natural compound. Melanoma Res;Epub 2010 Mar 17. 16. Griffin C, Hamm C, McNulty J, Pandey S (2010) Pancratistatin induces apoptosis in clinical leukemia samples with minimal effect on non-cancerous peripheral blood mononuclear cells. Cancer Cell Int 10: 6. 17. Griffin C, Karnik A, McNulty J, Pandey S (2011a) Pancratistatin selectively targets cancer cell mitochondria and reduces growth of human colon tumor xenografts. Molecular Cancer Therapeutics 10(1): 57–68. 18. Griffin C, McNulty J, Pandey S (2011b) Pancratistatin induces apoptosis and autophagy in metastatic prostate cancer cells. Int J Oncol 38(6): 1549–56. 19. Collins J, Rinner U, Moser M, Hudlicky T, Ghiviriga I, et al. (2010) Chemoenzymatic synthesis of Amaryllidaceae constituents and biological evaluation of their C-1 analogues. The next generation synthesis of 7- deoxypancratistatin and trans-dihydrolycoricidine. J Org Chem 75(9): 3069–84. 20. Borst P, Rottenberg S (2004) Cancer cell death by programmed necrosis? Drug Resist Updat 7(6): 321–4. [Epub 2005 Jan 11]. 21. Liu JJ, Lin M, Yu JY, Liu B, Bao JK (2010) Targeting apoptotic and autophagic pathways for cancer therapeutics. Cancer Lett 300(2): 105–14. [Epub 2010 Oct 30]. 22. Reed JC (2000) Mechanisms of Apoptosis. American Journal of Pathology 157(5): 1415–1430. 23. Earnshaw WC (1999) Apoptosis. A cellular poison cupboard. Nature 397(6718): 387–389. 24. Michael OH (2000) The biochemistry of apoptosis. Nature 407: 770–777. 25. Kroemer G, Mari n˜o G, Levine B (2010) Autophagy and the integrated stress response. Mol Cell 40(2): 280–93. 26. Levine B (2007) Cell biology: autophagy and cancer. Nature 446(7137): 745–7. 27. Gozuacik D, Kimchi A (2004) Autophagy as a cell death and tumor suppressor mechanism. Oncogene 23(16): 2891–906. 28. Patel BB, Majumdar AP (2009) Synergistic role of curcumin with current therapeutics in colorectal cancer: minireview. Nutr Cancer 61(6): 842–6. 29. Epelbaum R, Schaffer M, Vizel B, Badmaev V, Bar-Sela G (2010) Curcumin and gemcitabine in patients with advanced pancreatic cancer. Nutr Cancer 62(8): 1137–41. 30. Zhang G, Gurtu V, Kain SR, Yan G (1997) Early detection of apoptosis using a fluorescent conjugate of annexin V. Biotechniques 23(3): 525–31. 31. Madesh M, Hajno´czky G (2001) VDAC-dependent permeabilization of the outer mitochondrial membrane by superoxide induces rapid and massive cytochrome c release. J Cell Biol 155(6): 1003–15. [Epub 2001 Dec 10]. 32. Simon HU, Haj-Yehia A, Levi-Schaffer F (2000) Role of reactive oxygen species (ROS) in apoptosis induction. Apoptosis 5(5): 415–8. PST Analogue & Curcumin for Osteosarcoma Therapy 33. Batandier C, Leverve X, Fontaine E (2004) Opening of the mitochondrial permeability transition pore induces reactive oxygen species production at the level of the respiratory chain complex I. J Biol Chem 279(17): 17197–204. [Epub 2004 Feb 11]. 34. Cocheme´ HM, Murphy MP (2008) Complex I is the major site of mitochondrial superoxide production by paraquat. J Biol Chem 283(4): 1786–98. [Epub 2007 Nov 26]. 35. Degterev A, Boyce M, Yuan J (2003) A decade of caspases. Oncogene 22(53): 8543–67. 36. Dalby KN, Tekedereli I, Lopez-Berestein G, Ozpolat B (2010) Targeting the prodeath and prosurvival functions of autophagy as novel therapeutic strategies in cancer. Autophagy 6(3): 322–9. [Epub 2010 Apr 26]. 37. Kabeya Y, Mizushima N, Ueno T, Yamamoto A, Kirisako T, et al. (2000) LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing. EMBO J 19(21): 5720–8. 38. Pollack M, Leeuwenburgh C (2001) Apoptosis and Aging: Role of the Mitochondrial. Journal of Gerontology 11: 475–482. 39. Gregory CD, Devitt A (2004) The macrophage and the apoptotic cell: an innate immune interaction viewed simplistically? Immunology 113(1): 1–14. 40. Singal PK, Iliskovic N (1998) Doxorubicin-induced cardiomyopathy. N Engl J Med 1998 Sep 24;339(13): 900–5. 41. Ta LE, Espeset L, Podratz J, Windebank AJ (2006) Neurotoxicity of oxaliplatin and cisplatin for dorsal root ganglion neurons correlates with platinum-DNA binding. Neurotoxicology 27(6): 992–1002. Epub 2006 May 9. 42. Flombaum CD, Meyers PA (1999) High-dose leucovorin as sole therapy for methotrexate toxicity. J Clin Oncol 17(5): 1589–94. 43. Gurjal A, An T, Valdivieso M, Kalemkerian GP (1999) Etoposide-induced pulmonary toxicity. Lung Cancer 26(2): 109–12. 44. Loebstein R, Koren G (1998) Ifosfamide-induced nephrotoxicity in children: critical review of predictive risk factors. Pediatrics 101(6): E8. 45. Zilfou JT, Lowe SW (2009) Tumor suppressive functions of p53. Cold Spring Harb Perspect Biol 1(5): a001883. 46. Masuda H, Miller C, Koeffler HP, Battifora H, Cline MJ (1987) Rearrangement of the p53 gene in human osteogenic sarcomas. Proc Natl Acad Sci U S A 84(21): 7716–9. 47. Navaraj A, Mori T, El-Deiry WS (2005) Cooperation between BRCA1 and p53 in repair of cyclobutane pyrimidine dimers. Cancer Biol Ther 4(12): 1409–1414. 48. Susin SA, Lorenzo HK, Zamzami N, Marzo I, Snow BE, et al. (1999) Molecular characterization of mitochondrial apoptosis-inducing factor. Nature 397(6718): 441–6. 49. Li LY, Luo X, Wang X (2001) Endonuclease G is an apoptotic DNase when released from mitochondria. Nature 412(6842): 95–9. 50. Gogvadze V, Orrenius S, Zhivotovsky B (2008) Mitochondria in cancer cells: what is so special about them? Trends Cell Biol 18(4): 165–73. 51. Chen G, Wang F, Trachootham D, Huang P (2010) Preferential killing of cancer cells with mitochondrial dysfunction by natural compounds. Mitochondrion 10(6): 614–25. 52. Warburg O (1956) On the origin of cancer cells. Science 123(3191): 309–14. 53. Gambhir SS (2002) Molecular imaging of cancer with positron emission tomography. Nat Rev Cancer 2(9): 683–93. 54. Gatenby RA, Gillies RJ (2004) Why do cancers have high aerobic glycolysis? Nat Rev Cancer 4(11): 891–9. 55. DeBerardinis RJ, Lum JJ, Hatzivassiliou G, Thompson CB (2008) The biology of cancer: metabolic reprogramming fuels cell growth and proliferation. Cell Metab 7(1): 11–20. 56. Gogvadze V, Zhivotovsky B, Orrenius S (2010) The Warburg effect and mitochondrial stability in cancer cells. Mol Aspects Med 31(1): 60–74. 57. Plas DR, Thompson CB (2002) Cell metabolism in the regulation of programmed cell death. Trends Endocrinol Metab 13(2): 75–8. 58. Bonnet S, Archer SL, Allalunis-Turner J, Haromy A, Beaulieu C, et al. (2007) A mitochondria-K+ channel axis is suppressed in cancer and its normalization promotes apoptosis and inhibits cancer growth. Cancer Cell 11(1): 37–51. 59. Vander Heiden MG, Cantley LC, Thompson CB (2009) Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 324(5930): 1029–33. 60. Pastorino JG, Shulga N, Hoek JB (2002) Mitochondrial binding of hexokinase II inhibits Bax-induced cytochrome c release and apoptosis. J Biol Chem 277(9): 7610–8. 61. Green DR, Kroemer G (2004) The pathophysiology of mitochondrial cell death. Science 305(5684): 626–9. 62. Casellas P, Galiegue S, Basile AS (2002) Peripheral benzodiazepine receptors and mitochondrial function. Neurochem Int 40(6): 475–86. 63. Ovadje P, Chatterjee S, Griffin C, Tran C, Hamm C, et al. (2011) Selective induction of apoptosis through activation of caspase-8 in human leukemia cells (Jurkat) by dandelion root extract. J Ethnopharmacol 133(1): 86–91. [Epub 2010 Sep 16]. 64. Chatterjee SJ, Ovadje P, Mousa M, Hamm C, Pandey S (2011) The efficacy of dandelion root extract in inducing apoptosis in drug-resistant human melanoma cells. Evid Based Complement Alternat Med 2011: 129045. Epub 2010 Dec 30. 65. Ravindran J, Prasad S, Aggarwal BB (2009) Curcumin and cancer cells: how many ways can curry kill tumor cells selectively? AAPS J 11(3): 495–510. PLoS ONE | www.plosone.org 13 December 2011 | Volume 6 | Issue 12 | e28780